Neuren Pharmaceuticals Limited
NURPF
$10.97
-$1.31-10.67%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -11.72% | 4.49% | 149.43% | 141.97% | 470.45% |
| Total Receivables | 1,004.43% | 1,207.11% | 40.72% | 36.51% | 1,227.22% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -91.43% | -89.85% | -- | -- | 113.32% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 46.68% | 73.60% | 137.15% | 130.05% | 473.19% |
|
|
|||||
| Total Current Assets | 46.68% | 73.60% | 137.15% | 130.05% | 473.19% |
| Net Property, Plant & Equipment | -34.47% | -22.38% | 9.86% | 6.05% | 104.90% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1,118.40% | 1,342.15% | -93.13% | -93.33% | -- |
| Total Assets | 50.00% | 77.53% | 134.52% | 127.51% | 474.80% |
|
|
|||||
| Total Accounts Payable | 94.89% | 130.62% | 44.75% | 40.41% | 162.31% |
| Total Accrued Expenses | -52.14% | -43.36% | -- | -- | 282.06% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -1.09% | 17.06% | 54.81% | 50.19% | 5,536.82% |
| Total Other Current Liabilities | -1.09% | 17.06% | 54.81% | 50.19% | 5,536.82% |
| Total Current Liabilities | -2.85% | 14.98% | 49.62% | 45.15% | 2,455.90% |
|
|
|||||
| Total Current Liabilities | -2.85% | 14.98% | 49.62% | 45.15% | 2,455.90% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -2.76% | 15.08% | 50.10% | 45.62% | 2,455.90% |
|
|
|||||
| Common Stock & APIC | -13.33% | 2.57% | 4.06% | 0.95% | 3.51% |
| Retained Earnings | 326.71% | 405.02% | 165.62% | 163.66% | 132.44% |
| Treasury Stock & Other | 361.98% | 410.06% | 56.90% | 58.19% | 15.17% |
| Total Common Equity | 60.99% | 90.54% | 140.07% | 132.89% | 394.86% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 60.99% | 90.54% | 140.07% | 132.89% | 394.86% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 60.99% | 90.54% | 140.07% | 132.89% | 394.86% |
|
|
|||||